Purpose: To investigate clinical, anatomic, and electrophysiologic response after single intravitreal injection of bevacizumab for macular edema attributable to retinal vein occlusion.
Design: Prospective nonrandomized, interventional case series.
Methods: Twenty-one patients with macular edema attributable to vein occlusion received intravitreal injection of bevacizumab 1.